Rafferty Asset Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$16.8M Buy
156,378
+19,915
+15% +$2.14M 0.06% 173
2025
Q1
$13.8M Sell
136,463
-30,681
-18% -$3.1M 0.06% 199
2024
Q4
$14.9M Buy
167,144
+17,781
+12% +$1.59M 0.05% 210
2024
Q3
$12.5M Sell
149,363
-10,532
-7% -$883K 0.04% 242
2024
Q2
$12.3M Buy
159,895
+8,706
+6% +$670K 0.05% 250
2024
Q1
$10.4M Buy
151,189
+2,133
+1% +$146K 0.04% 260
2023
Q4
$8.62M Sell
149,056
-3,724
-2% -$215K 0.04% 318
2023
Q3
$8.07M Buy
152,780
+13,624
+10% +$719K 0.05% 282
2023
Q2
$7.53M Buy
139,156
+10,990
+9% +$594K 0.04% 308
2023
Q1
$6.41M Buy
128,166
+4,932
+4% +$247K 0.04% 324
2022
Q4
$5.7M Buy
123,234
+46,641
+61% +$2.16M 0.05% 350
2022
Q3
$2.97M Buy
76,593
+41,908
+121% +$1.62M 0.03% 417
2022
Q2
$1.29M Sell
34,685
-8,873
-20% -$331K 0.01% 572
2022
Q1
$1.93M Sell
43,558
-4,337
-9% -$192K 0.01% 610
2021
Q4
$2.04M Buy
47,895
+2,498
+6% +$106K 0.01% 655
2021
Q3
$1.97M Buy
45,397
+15,985
+54% +$694K 0.01% 638
2021
Q2
$1.26M Buy
29,412
+2,671
+10% +$114K 0.01% 804
2021
Q1
$1.03M Buy
26,741
+3,138
+13% +$121K 0.01% 762
2020
Q4
$849K Sell
23,603
-2,217
-9% -$79.7K 0.01% 550
2020
Q3
$987K Sell
25,820
-6,282
-20% -$240K 0.01% 582
2020
Q2
$1.13M Buy
32,102
+21,377
+199% +$750K 0.02% 508
2020
Q1
$350K Sell
10,725
-26,913
-72% -$878K 0.01% 404
2019
Q4
$1.7M Buy
+37,638
New +$1.7M 0.03% 436
2016
Q4
Sell
-26,043
Closed -$620K 458
2016
Q3
$620K Buy
+26,043
New +$620K 0.02% 309
2016
Q2
Sell
-85,196
Closed -$1.6M 512
2016
Q1
$1.6M Buy
+85,196
New +$1.6M 0.09% 170
2015
Q4
Sell
-77,617
Closed -$1.27M 533
2015
Q3
$1.27M Buy
+77,617
New +$1.27M 0.1% 186
2015
Q1
Sell
-60,214
Closed -$798K 564
2014
Q4
$798K Buy
+60,214
New +$798K 0.18% 127
2013
Q3
Sell
-15,629
Closed -$145K 174
2013
Q2
$145K Buy
+15,629
New +$145K 0.02% 262